GlassScriptPhysician profile
Arko Ghosh
NPI 1083296552
$7,402.63
in general payments reported to CMS, 2019-2025
13 companies · $2,657 in 2025
The $2,657 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $256 · 2023: $3,159 · 2024: $1,331 · 2025: $2,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,726 · Travel and Lodging: $3,420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,726.26 |
| Travel and Lodging | $3,419.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,727.92 | 2023-2025 | Envista Mx60 Iol, Trulign Iol, Crystalens Accommodating Iol (At-52ao) |
| Glaukos Corporation | $2,261.52 | 2024-2025 | Istent Infinite, Radius Xr, Travoprost Intraocular Implant - Idose |
| Alcon Vision LLC | $1,041.96 | 2022-2025 | Clareon, Hydrus Microstent, Acrysof Toric Aspheric Uv Absorbing Iol |
| Sight Sciences, INC. | $336.38 | 2024-2025 | Omni Surgical System |
| Abbvie INC. | $267.41 | 2023-2024 | |
| Carl Zeiss Meditec USA, INC. | $162.23 | 2024 | Humphrey Hfa, Callisto Eye |
| Rxsight INC | $134.40 | 2022 | |
| Genentech, INC. | $128.15 | 2025 | Vabysmo |
| Amgen INC. | $125.00 | 2024 | Tepezza |
| Genentech USA, INC. | $115.41 | 2023 | Vabysmo |
| Johnson & Johnson Surgical Vision, INC. | $44.17 | 2023-2024 | Veritas Vision System, Tecnis Simplicity |
| Rayner Intraocular Lenses Limited | $36.46 | 2025 | Omidria |
| Harrow Eye, LLC | $21.62 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arko Ghosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.